REQUEST INFORMATION
On Our Oncology Drug Development, Market Strategy, Launch Adoption, and Congress Coverage Services

PLEASE INDICATE AREAS OF INTEREST:
Oncology Drug Development Support:







Commercial Market Strategies & Oncology Launch Adoptions:






Cancer Indications of Interest:
























Trusted experts in drug launches, pharma prelaunch planning and marketing strategy, and clinical development timeline planning

Follow Us

Learn More

Please contact us regarding any questions you may have, or to learn more about our services. We look forward to hearing from you.

Contact Pennside Partners to learn more about our pharma oncology consulting services, including oncology congress coverage, launch planning, launch analog service, pipeline and CI analysis, oncology benchmarking, biomarker analysis, and more.

Pennside's Oncology Congress Coverage is Tailored to Your Unique Needs

Typically congress conference coverage emphasis is on new data release and resulting impressions and reactions from the KOL community as well as the identification of novel therapeutic targets / therapeutic approaches. Congresses attended are based on your needs, and may include those shown below, or others.

Congress conference coverage by Pennside Partners may include these and other conferences: San Antonio Breast Cancer Symposium, AARC, SNO, ASCO, IASLC, ESMO, and Kidney Cancer Association.

Oncology Drug Development Support,
Market Strategies, Launch Adoptions,
and Congress Coverage Services

Pennside's oncology pharma drug development consulting services offer industry and oncology market-specific programs within a broad range of functional areas

Offering Industry and Oncology Market-Specific Programs Within a Broad Range of Functional Areas

A Highly Specialized and Focused Oncology Team

We have a dedicated oncology consulting team of analysts and consultants who deal solely with the complex issues specific to oncology drug development. We provide our clients with the scientific and business acumen required for accurate analysis of competing MOAs and corporate strategies of companies engaged in drug development in the oncology arena.

Use our team of oncology drug development support experts, analysts, and consultants to solve complex oncology drug development issues

Oncology Drug Development Support for 6 Key Functional Areas

Our oncology drug development support strategy covers 6 important areas critical to your success:

1. Launch analog service: launch support, including marketing, sales, and benchmarking

2. Oncology congress coverage service

3. Post-launch intelligence and market monitoring

4. Oncology biomarker analysis

5. Business development and licensing / M&A support

6. Tumor / MOA clinical pipeline analysis


Optimizing Commercial Market Strategies & Oncology Launch Adoptions

Pennside’s dedicated oncology team provides the expertise required to optimize both oncology launch adoptions and commercial market strategies through a combination of: launch planning support, primary field-intelligence and market insights for oncology therapeutics, competitive pipeline analysis, inclicensing reviews, biomarker analysis, and benchmarking of oncology marketing organizations. 

Consuting-to-Optimize-Oncology-Launch-Adoptions-and-Commercial-Market-Strategies

Launch Planning Support

    • Core expertise on pre-launch and launch strategy consulting. Our key fields include Clinical, Regulatory, and Marketing & Sales & Strategy.
    • Analysis of previous oncology drug launches (Launch Analog Service).

Primary Field-Intelligence & Market Insights for Oncology Therapeutics

    • Pennside provides clients with useful, accurate business intelligence and market insights, so that they can make sound strategic and tactical decisions
    • Focus on critical details not available in published sources - information normally inaccessible to clients, yet necessary to make strategic decisions
    • Qualified staff who conduct in-depth, peer-to-peer interviews with industry participants at all levels of the healthcare value chain, including:  KOLs, MDs, Pharmacists, Scientists, Marketing & Sales Experts

Competitive Pipeline Analysis

    • Complete analysis of competitor drugs from both cancer indication perspective or MOA, put together with business analysis of a company’s ability to successfully launch a true competitive threat
      Learn more: Oncology pipeline analysis 

Inclicensing Reviews

    • Analysis of drug candidates/ companies suitable for partnering or in-licensing for oncology therapeutics

Biomarker Analysis

    • Review of efforts being made to “personalize” therapies for various agents in development and analysis of the likelihood of success

Benchmarking of Oncology Marketing Organizations 

    • Support with regard to strategic positioning, pricing and tactical implementation
    • Resourcing, field force, sales and peer influence activities
    • Benchmarking of detailed clinical and marketing spend levels

 


Providing Oncology Congress Coverage Uniquely Tailored to Your Needs

Pennside’s oncology conference coverage service is uniquely tailored to your specific needs. From preparation, to congress attendance, to wrap-up, our process provides the information and field-intelligence to support a focused and targeted oncology strategy. 

Pennside provides oncology conference coverage services for pharma clients. Improve your competitive pharmaceutical product positioning and gather key intelligence from our thorough analysis and reporting.

 

Step 1: Congress Preparation

We’ll create a congress schedule that includes presentations of particular interest. A range of cancer indications and issues will be selected for coverage, including key intelligence topics important to your strategy.

Step 2: Congress Attendance

Pennside will attend each conference, gathering key intelligence, including:

    • Digital image capture of key presentation slides
    • Personal coverage of Key corporate-sponsored symposia, oral, plenary, late-breaking and poster sessions
    • Personal interviews with KOLs, MDs, and industry contacts
    • Collection of booth materials with analysis of competitive product positioning and key messaging themes 

Step 3: Congress Wrap Up

The wrap up will include both high-level and detailed information as follows:

    • Formal presentation of answers to key intelligence topics as well as other major findings
    • Provision of a summary congress report (PowerPoint document)
    • Provision of full congress report CD-ROM containing images of key posters, presentations, and exhibits


Oncology Consulting - Learn More

To learn more about our extensive range of consulting services for the pharmaceutical and biotechnology industries, contact Pennside at our US or EU offices. 

Contact us to learn more about our oncology consulting services for the pharmaceutical and biotechnology industries

A pharma and biotech consulting firm offering pipeline, benchmarking, launch analog, launch planning, business intelligence, business analysis, and competitive intelligence relating to oncology, respiratory, cardiovascular, immunology, and diabetes areas for the pharmaceutical and biotechnology industries